A Study to evaluate the utility of the ProLung China Test as an adjunct to CT scan in the diagnosis of lung cancer.
This Study will assess the stability of the ProLung China Test classification algorithm when used as an adjunct to CT scan. This Study will assess whether there are any potential safety concerns of the ProLung China Test when used to evaluate patients with a positive CT scan for lung cancer.
Study Type
OBSERVATIONAL
Enrollment
500
Nantong Tumor Hospital
Nantong, Jiangsu, China
RECRUITINGShanghai Dongfang Hospital of Tongji University
Shanghai, Shanghai Municipality, China
RECRUITINGZhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
RECRUITINGSafety and Efficacy of the ProLung China Test
Demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer.
Time frame: The ProLung China Test will be performed within 30 days of a CT Scan that identifies a lung lesion suspicious for lung cancer and evaluated once a patient diagnosis is obtained.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.